{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:33:15Z","timestamp":1788489195466,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["64.310\/436\/2565"],"award-info":[{"award-number":["64.310\/436\/2565"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["HEA663000016"],"award-info":[{"award-number":["HEA663000016"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010804","name":"Faculty of Medicine, Prince of Songkla University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004776","name":"Faculty of Medicine, Chulalongkorn University","doi-asserted-by":"publisher","award":["RA66\/016"],"award-info":[{"award-number":["RA66\/016"]}],"id":[{"id":"10.13039\/501100004776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.isci.2025.113048","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T02:56:21Z","timestamp":1751684181000},"page":"113048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["HHV-6 and EBV reactivation in relapsing remitting multiple sclerosis: Disability, progression, and inflammation links"],"prefix":"10.1016","volume":"28","author":[{"given":"Abbas F.","family":"Almulla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristo","family":"Vojdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elroy","family":"Vojdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.113048_bib1","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3390\/cimb45020094","article-title":"Multiple Sclerosis: Inflammatory and Neuroglial Aspects","volume":"45","author":"Papiri","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.isci.2025.113048_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2008.06.029","article-title":"Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity","volume":"274","author":"Gonsette","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.isci.2025.113048_bib3","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1007\/s12035-015-9443-4","article-title":"Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation","volume":"53","author":"Kallaur","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.isci.2025.113048_bib4","first-page":"73","article-title":"Cognitive impairment in multiple sclerosis","volume":"103","author":"Jongen","year":"2012","journal-title":"Minerva Med."},{"key":"10.1016\/j.isci.2025.113048_bib5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3390\/brainsci13071073","article-title":"Mood Symptoms and Chronic Fatigue Syndrome Due to Relapsing-Remitting Multiple Sclerosis Are Associated with Immune Activation and Aberrations in the Erythron","volume":"13","author":"Almulla","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.isci.2025.113048_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archneurol.2009.190","article-title":"Multiple Sclerosis With Predominant, Severe Cognitive Impairment","volume":"66","author":"Staff","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.isci.2025.113048_bib7","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.isci.2025.113048_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neurol.2015.10.006","article-title":"Epidemiology of multiple sclerosis","volume":"172","author":"Leray","year":"2016","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.isci.2025.113048_bib9","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2025.113048_bib10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1191\/1352458505ms1240oa","article-title":"Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity","volume":"11","author":"Ferretti","year":"2005","journal-title":"Mult. Scler."},{"key":"10.1016\/j.isci.2025.113048_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2012.07.045","article-title":"Oxidative stress in multiple sclerosis patients in clinical remission: Association with the expanded disability status scale","volume":"321","author":"Oliveira","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.isci.2025.113048_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/725370","article-title":"Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis","volume":"2015","author":"Haider","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.isci.2025.113048_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061835","article-title":"Characteristic cerebrospinal fluid cytokine\/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis","volume":"8","author":"Matsushita","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.113048_bib14","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s11011-019-00456-7","article-title":"Disability in multiple sclerosis is associated with age and inflammatory, metabolic and oxidative\/nitrosative stress biomarkers: results of multivariate and machine learning procedures","volume":"34","author":"Flauzino","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.isci.2025.113048_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106031","article-title":"Association between human herpesviruses and multiple sclerosis: A systematic review and meta-analysis","volume":"177","author":"Khalesi","year":"2023","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.isci.2025.113048_bib16","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.3389\/fimmu.2019.02715","article-title":"Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis","volume":"10","author":"Engdahl","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.113048_bib17","doi-asserted-by":"crossref","first-page":"e00143-20","DOI":"10.1128\/CMR.00143-20","article-title":"Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation","volume":"34","author":"Komaroff","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.isci.2025.113048_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.840753","article-title":"Human Herpesvirus 6A Is a Risk Factor for Multiple Sclerosis","volume":"13","author":"Lundstr\u00f6m","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.113048_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240601","article-title":"Search for viral agents in cerebrospinal fluid in patients with multiple sclerosis using real-time PCR and metagenomics","volume":"15","author":"Perlejewski","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.113048_bib20","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/jmv.21764","article-title":"Detection of viral DNA sequences in the cerebrospinal fluid of patients with multiple sclerosis","volume":"82","author":"Mancuso","year":"2010","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.isci.2025.113048_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094497","article-title":"Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis","volume":"9","author":"Cocuzza","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.113048_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/1352458509357066","article-title":"Antiviral immune response in patients with multiple sclerosis and healthy siblings","volume":"16","author":"Comabella","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.isci.2025.113048_bib23","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.WNL.0000130496.51156.D7","article-title":"An altered immune response to Epstein-Barr virus in multiple sclerosis","volume":"62","author":"Sundstr\u00f6m","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2025.113048_bib24","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/01.WNL.0000069461.53733.F7","article-title":"The immune response against herpesvirus is more prominent in the early stages of MS","volume":"60","author":"Villoslada","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2025.113048_bib25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1212\/WNL.0b013e3181aa29fe","article-title":"Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI","volume":"73","author":"Farrell","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2025.113048_bib26","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1177\/1352458514533843","article-title":"Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis","volume":"20","author":"Kvistad","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.isci.2025.113048_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104149","article-title":"Epstein-Barr virus antibody in newly diagnosed multiple sclerosis patients and its association with relapse severity and lesion location","volume":"68","author":"Olmez","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.isci.2025.113048_bib28","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1136\/jnnp.2010.226340.160","article-title":"POI19 EBNA-1 IgG is not a reliable clinical marker of multiple sclerosis disease activity","volume":"81","author":"Ingram","year":"2010","journal-title":"J. Neurol. Neurosurgery Psychiatry"},{"key":"10.1016\/j.isci.2025.113048_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175279","article-title":"Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis","volume":"12","author":"Gie\u00df","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.113048_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202200527","article-title":"Targeting Epstein-Barr virus dUTPase, an immunomodulatory protein using antiviral, anti-inflammatory, and neuroprotective phytochemicals","volume":"19","author":"Tiwari","year":"2022","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.isci.2025.113048_bib31","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1099\/0022-1317-77-11-2795","article-title":"Cloning and expression of the Epstein\u2014Barr virus-encoded dUTPase: patients with acute, reactivated or chronic virus infection develop antibodies against the enzyme","volume":"77","author":"Sommer","year":"1996","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.isci.2025.113048_bib32","series-title":"Modulation of the Innate Immune Response by the Oncoviruses EBV and HPV","author":"Parroche","year":"2011"},{"key":"10.1016\/j.isci.2025.113048_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens6010002","article-title":"Herpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human Disease","volume":"6","author":"Williams","year":"2016","journal-title":"Pathogens"},{"key":"10.1016\/j.isci.2025.113048_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1352458507080063","article-title":"Human herpes virus 6 and multiple sclerosis: a Finnish twin study","volume":"14","author":"Kuusisto","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.isci.2025.113048_bib35","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1002\/jmv.27728","article-title":"Examination of control asymptomatic cohorts reveals heightened anti-EBV and HHV-6 A\/B dUTPase antibodies in the aging populations","volume":"94","author":"Alharshawi","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.isci.2025.113048_bib36","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3390\/cancers15030855","article-title":"EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies","volume":"15","author":"Williams","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2025.113048_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103561","article-title":"Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progression","volume":"59","author":"Tao","year":"2022","journal-title":"Multiple Sclerosis Related Disord."},{"key":"10.1016\/j.isci.2025.113048_bib38","first-page":"4","article-title":"Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease","volume":"12","author":"Fotheringham","year":"2005","journal-title":"Herpes"},{"key":"10.1016\/j.isci.2025.113048_bib39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmii.2010.08.002","article-title":"Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis","volume":"44","author":"Behzad-Behbahani","year":"2011","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.isci.2025.113048_bib40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13365-012-0138-6","article-title":"Prevalence of human herpesvirus U94\/REP antibodies and DNA in Tunisian multiple sclerosis patients","volume":"19","author":"Ben-Fredj","year":"2013","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.isci.2025.113048_bib41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.113048_bib42","article-title":"Molecular Mimicry Between Epstein-Barr Virus and Human Herpesvirus-6 Proteins and Central Nervous System Proteins: Implications for T and B Cell Immunogenicity in an In Silico Study","author":"Almulla","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2025.113048_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1334720","article-title":"Enhanced and cross-reactive in vitro memory B cell response against Epstein-Barr virus nuclear antigen 1 in multiple sclerosis","volume":"15","author":"Marti","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.113048_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1487523","article-title":"In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis","volume":"15","author":"Vasilenko","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.113048_bib45","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/1352458511428081","article-title":"Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis","volume":"18","author":"Simpson","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.isci.2025.113048_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104836","article-title":"Anti-Human Herpesvirus 6A\/B IgG Correlates with Relapses and Progression in Multiple Sclerosis","volume":"9","author":"Ortega-Madue\u00f1o","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.113048_bib47","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/ane.12268","article-title":"EBV & HHV6 reactivation is infrequent and not associated with MS clinical course","volume":"130","author":"Simpson","year":"2014","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.isci.2025.113048_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1134\/S1607672924700753","article-title":"The Level of Anti-Viral Antigen-Specific Antibodies to EBNA-1 in the Serum of MS Patients Does not Depend on the Severity of the Disease","volume":"515","author":"Ovchinnikova","year":"2024","journal-title":"Dokl. Biochem. Biophys."},{"key":"10.1016\/j.isci.2025.113048_bib49","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1177\/1352458519866613","article-title":"Age-related decreases in relapses among adults with relapsing-onset multiple sclerosis","volume":"26","author":"Schwehr","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.isci.2025.113048_bib50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000079936","article-title":"Beta-Interferon Treatment Reduces Human Herpesvirus-6 Viral Load in Multiple Sclerosis Relapses but Not in Remission","volume":"52","author":"\u00c1lvarez-Lafuente","year":"2004","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.isci.2025.113048_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002028","article-title":"Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients","volume":"3","author":"Yao","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.113048_bib52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jneuroim.2017.03.013","article-title":"Massive intracerebral Epstein-Barr virus reactivation in lethal multiple sclerosis relapse after natalizumab withdrawal","volume":"307","author":"Serafini","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.isci.2025.113048_bib53","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1177\/1352458515576984","article-title":"Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis","volume":"21","author":"Kohlmann","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.isci.2025.113048_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160277","article-title":"Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation","volume":"11","author":"Iannetta","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.113048_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71283-5","article-title":"Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab","volume":"10","author":"Dom\u00ednguez-Mozo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.113048_bib56","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nri702","article-title":"Cytokines and autoimmunity","volume":"2","author":"O'Shea","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2025.113048_bib57","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3390\/biom12020227","article-title":"Viral dUTPases: Modulators of Innate Immunity","volume":"12","author":"Ariza","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.isci.2025.113048_bib58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbi.2007.07.007","article-title":"Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: Evidence for depression-induced atherosclerotic risk","volume":"22","author":"Waldman","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.isci.2025.113048_bib59","doi-asserted-by":"crossref","first-page":"e01148-17","DOI":"10.1128\/JVI.01148-17","article-title":"Pseudorabies Virus dUTPase UL50 Induces Lysosomal Degradation of Type I Interferon Receptor 1 and Antagonizes the Alpha Interferon Response","volume":"91","author":"Zhang","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2025.113048_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577313","article-title":"The role of human herpesvirus-6 and inflammatory markers in the pathogenesis of multiple sclerosis","volume":"346","author":"Keyvani","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.isci.2025.113048_bib61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jmv.10258","article-title":"Correlation between HHV-6 reactivation and multiple sclerosis disease activity","volume":"69","author":"Chapenko","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.isci.2025.113048_bib62","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5603\/PJNNS.a2020.0037","article-title":"Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors","volume":"54","author":"Sapko","year":"2020","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.isci.2025.113048_bib63","first-page":"19","article-title":"Biomarkers of multiple sclerosis: current findings","volume":"7","author":"Harris","year":"2017","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"10.1016\/j.isci.2025.113048_bib64","doi-asserted-by":"crossref","first-page":"12952","DOI":"10.1073\/pnas.1912839117","article-title":"Inflammation-related plasma and CSF biomarkers for multiple sclerosis","volume":"117","author":"Huang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.113048_bib65","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2169\/internalmedicine.53.1246","article-title":"Biomarkers for multiple sclerosis","volume":"53","author":"Tomioka","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.isci.2025.113048_bib66","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12035-015-9648-6","article-title":"Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis","volume":"54","author":"Kallaur","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.isci.2025.113048_bib67","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s12035-019-01856-7","article-title":"Antioxidant and Anti-inflammatory Diagnostic Biomarkers in Multiple Sclerosis: A Machine Learning Study","volume":"57","author":"Mezzaroba","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.isci.2025.113048_bib68","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.isci.2025.113048_bib69","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2025.113048_bib70","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2025.113048_bib71","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/geront\/10.1_Part_1.20","article-title":"Progress in development of the index of ADL","volume":"10","author":"Katz","year":"1970","journal-title":"Gerontol."},{"key":"10.1016\/j.isci.2025.113048_bib72","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1038\/s41598-018-22058-6","article-title":"Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis","volume":"8","author":"Trier","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.113048_bib73","article-title":"Brain-targeted autoimmunity is strongly associated with Long COVID and its chronic fatigue syndrome as well as its affective symptoms","author":"Almulla","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.isci.2025.113048_bib74","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/cells11071183","article-title":"The immune profile of major dysmood disorder: proof of concept and mechanism using the precision nomothetic psychiatry approach","volume":"11","author":"Maes","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.isci.2025.113048_bib75","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12888-022-04021-y","article-title":"Delirium due to hip fracture is associated with activated immune-inflammatory pathways and a reduction in negative immunoregulatory mechanisms","volume":"22","author":"Thisayakorn","year":"2022","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.isci.2025.113048_bib76","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jare.2023.11.012","article-title":"T helper-1 activation via interleukin-16 is a key phenomenon in the acute phase of severe, first-episode major depressive disorder and suicidal behaviors","volume":"64","author":"Almulla","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.isci.2025.113048_bib77","doi-asserted-by":"crossref","first-page":"8885","DOI":"10.1007\/s12035-018-1016-x","article-title":"The compensatory immune-regulatory reflex system (CIRS) in depression and bipolar disorder","volume":"55","author":"Maes","year":"2018","journal-title":"Mol. Neurobiol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225013094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225013094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:27:11Z","timestamp":1778902031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225013094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2589004225013094"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.113048","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HHV-6 and EBV reactivation in relapsing remitting multiple sclerosis: Disability, progression, and inflammation links","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.113048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113048"}}